INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 250 filers reported holding INARI MED INC in Q2 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,264,000 | +349.9% | 80,489 | +300.0% | 0.01% | +600.0% |
| Q2 2023 | $1,170,000 | -95.3% | 20,122 | -95.0% | 0.00% | -96.6% |
| Q1 2023 | $24,825,000 | -78.5% | 402,093 | -77.8% | 0.03% | -78.7% |
| Q4 2022 | $115,352,000 | -37.2% | 1,814,852 | -28.2% | 0.14% | -39.6% |
| Q3 2022 | $183,670,000 | -6.4% | 2,527,995 | -12.4% | 0.22% | +2.3% |
| Q2 2022 | $196,201,000 | -25.7% | 2,885,730 | -0.9% | 0.22% | +9.5% |
| Q1 2022 | $263,945,000 | +0.7% | 2,912,019 | +1.4% | 0.20% | -7.8% |
| Q4 2021 | $262,060,000 | +19.4% | 2,871,262 | +6.1% | 0.22% | +16.6% |
| Q3 2021 | $219,513,000 | -8.9% | 2,706,695 | +4.8% | 0.19% | -5.6% |
| Q2 2021 | $240,846,000 | +15.2% | 2,581,965 | +32.1% | 0.20% | -33.1% |
| Q1 2021 | $209,094,000 | +337.8% | 1,954,154 | +257.2% | 0.30% | +322.9% |
| Q4 2020 | $47,755,000 | +1355.1% | 547,083 | +1050.3% | 0.07% | +1066.7% |
| Q3 2020 | $3,282,000 | +7.1% | 47,558 | -24.8% | 0.01% | +20.0% |
| Q2 2020 | $3,064,000 | – | 63,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,426,584 | $115,696,000 | 3.81% |
| Affinity Asset Advisors, LLC | 135,000 | $10,949,000 | 2.76% |
| SECTORAL ASSET MANAGEMENT INC | 289,650 | $23,491,000 | 1.95% |
| Pier Capital, LLC | 99,434 | $8,064,000 | 0.84% |
| Beck Bode, LLC | 27,853 | $2,259,000 | 0.63% |
| CNA FINANCIAL CORP | 22,993 | $1,865,000 | 0.51% |
| NEXT CENTURY GROWTH INVESTORS LLC | 59,245 | $4,804,000 | 0.42% |
| Birchview Capital, LP | 7,000 | $568,000 | 0.39% |
| PDT Partners, LLC | 59,849 | $4,854,000 | 0.35% |
| HAMILTON LANE ADVISORS LLC | 24,900 | $2,019,000 | 0.34% |